These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 15613060)

  • 1. ACE inhibitors improve nephrin expression in Zucker rats with glomerulosclerosis.
    Blanco S; Bonet J; López D; Casas I; Romero R
    Kidney Int Suppl; 2005 Jan; (93):S10-4. PubMed ID: 15613060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of antihypertensive drugs in experimental type 2 diabetes-related nephropathy.
    Blanco S; Penin R; Casas I; López D; Romero R
    Kidney Int Suppl; 2002 Dec; (82):S27-31. PubMed ID: 12410851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential role of angiotensin-converting enzyme inhibitors and statins on early podocyte damage in a model of type 2 diabetes mellitus, obesity, and mild hypertension.
    Blanco S; Vaquero M; Gómez-Guerrero C; López D; Egido J; Romero R
    Am J Hypertens; 2005 Apr; 18(4 Pt 1):557-65. PubMed ID: 15831368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of the slit-diaphragm protein, nephrin, in experimental diabetic nephropathy: differing effects of anti-proteinuric therapies.
    Kelly DJ; Aaltonen P; Cox AJ; Rumble JR; Langham R; Panagiotopoulos S; Jerums G; Holthöfer H; Gilbert RE
    Nephrol Dial Transplant; 2002 Jul; 17(7):1327-32. PubMed ID: 12105259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronically increased intrarenal angiotensin II causes nephropathy in an animal model of type 2 diabetes.
    Sharma R; Sharma M; Reddy S; Savin VJ; Nagaria AM; Wiegmann TB
    Front Biosci; 2006 Jan; 11():968-76. PubMed ID: 16146787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of angiotensin-converting enzyme inhibition and calcium channel blockade on cardiac apoptosis in rats with 2K1C (two-kidney/one-clip) renovascular hypertension.
    Thöne-Reineke C; Olivier J; Godes M; Zart R; George I; Bauer C; Neumayer HH; Hocher B
    Clin Sci (Lond); 2003 Jan; 104(1):79-85. PubMed ID: 12519090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiorenal protective effects of year-long antihypertensive therapy with an angiotensin-converting enzyme inhibitor or a calcium channel blocker in spontaneously hypertensive rats.
    Ishimitsu T; Honda T; Ohta S; Akashiba A; Takahashi T; Kameda T; Yoshii M; Minami J; Takahashi M; Ono H; Matsuoka H
    Am J Hypertens; 2006 Dec; 19(12):1233-40. PubMed ID: 17161768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of antihypertensive drugs on blood pressure and metabolic alterations in the fructose-induced hypertensive rat.
    Navarro-Cid J; Maeso R; Perez-Vizcaino F; Casal MC; Cachofeiro V; Ruilope LM; Tamargo J; Lahera V
    Am J Hypertens; 1996 Jul; 9(7):669-74. PubMed ID: 8806979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of angiotensin receptor blocker on phenotypic alterations of podocytes in early diabetic nephropathy.
    Dai HY; Zheng M; Tang RN; Ni J; Ma KL; Li Q; Liu BC
    Am J Med Sci; 2011 Mar; 341(3):207-14. PubMed ID: 21326079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin sensitivity, glucose effectiveness, and beta-cell function in obese males with essential hypertension: investigation of the effects of treatment with a calcium channel blocker (diltiazem) or an angiotensin-converting enzyme inhibitor (quinapril).
    Cabezas-Cerrato J; Garcia-Estevez DA; Araújo D; Iglesias M
    Metabolism; 1997 Feb; 46(2):173-8. PubMed ID: 9030825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteinuria and the expression of the podocyte slit diaphragm protein, nephrin, in diabetic nephropathy: effects of angiotensin converting enzyme inhibition.
    Langham RG; Kelly DJ; Cox AJ; Thomson NM; Holthöfer H; Zaoui P; Pinel N; Cordonnier DJ; Gilbert RE
    Diabetologia; 2002 Nov; 45(11):1572-6. PubMed ID: 12436341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ACE-inhibitors but not endothelin receptor blockers prevent podocyte loss in early diabetic nephropathy.
    Gross ML; El-Shakmak A; Szábó A; Koch A; Kuhlmann A; Münter K; Ritz E; Amann K
    Diabetologia; 2003 Jun; 46(6):856-68. PubMed ID: 12802493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Irbesartan normalises the deficiency in glomerular nephrin expression in a model of diabetes and hypertension.
    Bonnet F; Cooper ME; Kawachi H; Allen TJ; Boner G; Cao Z
    Diabetologia; 2001 Jul; 44(7):874-7. PubMed ID: 11508272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of dehydroepiandrosterone and quinapril on nephropathy in obese Zucker rats.
    Richards RJ; Porter JR; Inserra F; Ferder LF; Stella I; Reisin E; Svec F
    Kidney Int; 2001 Jan; 59(1):37-43. PubMed ID: 11135055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiotensin converting enzyme inhibition enhances collateral artery remodeling in rats with femoral artery occlusion.
    Ren J; Li H; Prior BM; Yang HT
    Am J Med Sci; 2008 Mar; 335(3):177-87. PubMed ID: 18344690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vasopeptidase inhibition attenuates proteinuria and podocyte injury in Zucker diabetic fatty rats.
    Fredersdorf S; Weil J; Ulucan C; Birner C; Büttner R; Schubert T; Böger CA; Debl K; Muders F; Riegger GA; Luchner A
    Naunyn Schmiedebergs Arch Pharmacol; 2007 Apr; 375(2):95-103. PubMed ID: 17333128
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early events leading to renal injury in obese Zucker (fatty) rats with type II diabetes.
    Coimbra TM; Janssen U; Gröne HJ; Ostendorf T; Kunter U; Schmidt H; Brabant G; Floege J
    Kidney Int; 2000 Jan; 57(1):167-82. PubMed ID: 10620198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of arterial thrombogenesis by quinapril but not losartan.
    Bavry AA; Li D; Zander DS; Phillips MI; Mehta JL
    J Cardiovasc Pharmacol Ther; 2000 Apr; 5(2):121-7. PubMed ID: 11150391
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Effect of Combined Treatment with the (Pro)Renin Receptor Blocker HRP and Quinapril in Type 1 Diabetic Rats.
    Kökény G; Fang L; Révész C; Mózes MM; Vörös P; Szénási G; Rosivall L
    Kidney Blood Press Res; 2017; 42(1):109-122. PubMed ID: 28359068
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional and partial morphological regression of established renal injury in the obese zucker rat by blockade of the renin-angiotensin system.
    Sebeková K; Lill M; Boor P; Heidland A; Amann K
    Am J Nephrol; 2009; 29(3):164-70. PubMed ID: 18753741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.